China Cord Blood Corp. (CO) Tops Q1 EPS by 1c

China Cord Blood Corp. (NYSE: CO) reported Q1 EPS of $0.06, $0.01 better than the analyst estimate of $0.05. Revenue for the quarter came in at $24.7 million versus the consensus estimate of $24.8 million.

For earnings history and earnings-related data on China Cord Blood Corp. (CO) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M